Hyperliquid shakes up the crypto market with a spectacular rise of 11.91%. This surge comes as the company unveils ambitious plans: an IPO on the Nasdaq and a billion-dollar fundraising. Institutional investors are closely monitoring this project which aims to become a bridge between decentralized finance and traditional markets.
In brief
- Hyperliquid price jumps 11.91% and crosses the 200-day simple moving average at $39.02.
- Hyperliquid Strategies Inc. files S-1 with the SEC to raise up to $1 billion via 160 million shares.
- The merger between Sonnet BioTherapeutics and Rorschach I LLC creates a Nasdaq-listed crypto management company.
- The funds will be used to develop the ecosystem and accumulate HYPE tokens through redemptions and staking.
Hyperliquid breaks crucial resistance
The HYPE token has just crossed a crucial psychological threshold. After recovering the Fibonacci level at 61.8% ($35.84), it now shatters the 200-day moving average, a technical signal that seasoned traders have been watching for weeks.
This performance takes place in a particular context: the platform recently activated its HIP-3 upgrade on October 13, now allowing any developer to create perpetual markets without prior authorization.
Volumes are exploding, revealing sharply increasing institutional demand. “Whales” massively accumulate leveraged long positions. This buying frenzy is no coincidence. She anticipates a major event that could redefine Hyperliquid's position in the crypto ecosystem.
The next hurdle lies at $41.76. A clear crossing of this resistance would validate a long-term bullish reversal. For now, the dynamic remains favorable. Technical indicators are converging towards a continuation of the rally, in particular thanks to sustained volumes and constant buying pressure.
Hyperliquid's capitalization now reaches $11.4 billion. This impressive figure places the project among the major players in decentralized finance. Analysts emphasize that this valuation remains justified in view of current developments.
An unprecedented bridge between DeFi and traditional finance
The origin of this outbreak? A Explosive S-1 filing with the US SEC. Hyperliquid Strategies Inc., born from the merger between Sonnet BioTherapeutics (listed on Nasdaq) and Rorschach I LLC, aims to raise up to $1 billion.
The issue provides for 160 million shares, a large-scale operation which demonstrates the confidence of institutional investors.
The funds raised will finance the expansion of the Hyperliquid ecosystem and the strategic accumulation of HYPE tokens. A substantial portion will be allocated to token redemptions on the secondary market, mechanically creating additional buying pressure. The rest will fuel staking operations, thus reducing the available circulating supply.
This “treasury management” strategy is reminiscent of that adopted by MicroStrategy for Bitcoin. It aims to transform Hyperliquid into a publicly traded institutional investment vehicle.
Traditional fund managers will thus be able to obtain regulated exposure to DeFi without directly managing crypto portfolios.
Open interest in HYPE derivatives markets now exceeds $2 billion. This record level illustrates the growing confidence in the platform. However, this meteoric rise is not without risks.
The crash of October 11, 2025 caused more than $10.3 billion in liquidations, surpassing even Binance and Bybit. This turbulence revealed certain technical flaws which still fuel concerns.
Maximize your Tremplin.io experience with our 'Read to Earn' program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.
